Janus Henderson Group PLC Jazz Pharmaceuticals PLC Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Janus Henderson Group PLC holds 27,200 shares of JAZZ stock, worth $3.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,200

Previous 6,280 333.12%

Holding current value

$3.47 Million

Previous $756,000 283.99%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$103.94 - $118.98 $2.17 Million - $2.49 Million	20,920 Added 333.12%	27,200 $2.9 Million
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $5,598 - $6,664	-49 Reduced 0.77%	6,280 $772,000
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $38.5 Million - $45.9 Million	-315,871 Reduced 98.04%	6,329 $819,000
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $44.2 Million - $53.1 Million	-360,773 Reduced 52.82%	322,200 $39.9 Million
Q1 2023 May 15, 2023	SELL	$133.98 - $160.47 $55.5 Million - $66.4 Million	-413,870 Reduced 37.73%	682,973 $99.9 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $18.4 Million - $22.7 Million	-142,057 Reduced 11.47%	1,096,843 $175 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $13 Million - $16.6 Million	102,865 Added 9.05%	1,238,900 $165 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $7.86 Million - $9.36 Million	55,508 Added 5.14%	1,136,035 $177 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $18.6 Million - $23 Million	143,140 Added 15.27%	1,080,527 $168 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $3.67 Million - $4.46 Million	30,626 Added 3.38%	937,387 $119 Million
Q3 2021 Nov 16, 2021	BUY	$128.64 - $184.79 $9.82 Million - $14.1 Million	76,353 Added 9.19%	906,761 $118 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $1.12 Million - $1.31 Million	7,007 Added 0.85%	830,408 $148 Million
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $7.24 Million - $8.36 Million	-48,199 Reduced 5.53%	823,401 $135 Million
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $8.7 Million - $10.2 Million	-61,798 Reduced 6.62%	871,600 $144 Million
Q3 2020 Nov 16, 2020	BUY	$105.46 - $144.13 $6.6 Million - $9.02 Million	62,594 Added 7.19%	933,398 $133 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $4.29 Million - $5.46 Million	44,819 Added 5.43%	870,804 $96.1 Million
Q1 2020 May 14, 2020	BUY	$87.74 - $152.74 $12.5 Million - $21.8 Million	142,652 Added 20.88%	825,985 $82.4 Million
Q4 2019 Feb 18, 2020	SELL	$117.65 - $153.73 $1.67 Million - $2.18 Million	-14,184 Reduced 2.03%	683,333 $102 Million
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $45,690 - $52,282	365 Added 0.05%	697,517 $89.4 Million
Q2 2019 Jul 31, 2019	BUY	$125.55 - $144.48 $1.06 Million - $1.22 Million	8,473 Added 1.23%	697,152 $99.4 Million
Q1 2019 Apr 30, 2019	SELL	$121.81 - $142.95 $317,802 - $372,956	-2,609 Reduced 0.38%	688,679 $98.4 Million
Q4 2018 Feb 06, 2019	SELL	$115.94 - $166.74 $20.1 Million - $28.9 Million	-173,595 Reduced 20.07%	691,288 $85.7 Million
Q3 2018 Nov 09, 2018	BUY	$161.01 - $180.57 $204,321 - $229,143	1,269 Added 0.15%	864,883 $145 Million
Q2 2018 Aug 10, 2018	SELL	$146.33 - $183.18 $9.44 Million - $11.8 Million	-64,493 Reduced 6.95%	863,614 $149 Million
Q1 2018 May 14, 2018	SELL	$135.59 - $157.16 $261,281 - $302,847	-1,927 Reduced 0.21%	928,107 $140 Million
Q4 2017 Feb 09, 2018	BUY	$131.06 - $150.39 $9.98 Million - $11.4 Million	76,114 Added 8.91%	930,034 $125 Million
Q3 2017 Nov 14, 2017	SELL	$142.62 - $155.6 $2.85 Million - $3.11 Million	-19,999 Reduced 2.29%	853,920 $0
Q2 2017 Aug 17, 2017	BUY	N/A	873,919	873,919 $136 Million

Others Institutions Holding JAZZ

# of Institutions

507

Shares Held

55.7M

Call Options Held

170K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Jazz Pharmaceuticals PLC Transaction History